OPTN/SRTR 2011 Annual Data Report: Liver

American Journal of Transplantation

Volumn 13, Issue SUPPL. 1, 2013, Pages 73-102

  Kim, W R ^a,b   Stock, P G ^a,c   Smith, J M ^a,d   Heimbach, J K ^e   Skeans, M A ^a   Edwards, E B ^f,g   Harper, A M ^f,g   Snyder, J J ^a,h   Israni, A K ^a,h,i   Kasiske, B L ^a,i  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e Mayo Clinic   (United States)

^f Organ Procurement and Transplantation Network   (United States)

^g UNITED NETWORK FOR ORGAN SHARING   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Liver transplant; Model for end stage liver disease; Pediatric end stage liver disease; Transplant outcomes

Indexed keywords

STEROID; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ARTICLE; CADAVER DONOR; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE POLICY; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER; LIVER TRANSPLANTATION; LIVING DONOR; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; RESOURCE ALLOCATION; TREATMENT OUTCOME; DONOR;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LIVING DONORS; TISSUE DONORS; WAITING LISTS;

EID: 84877600888     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12021     Document Type: Article

References (0)